HALO logo
halo search icon
Karyopharm Therapeutics, Inc.
Karyopharm Therapeutics, Inc.
KPTI · NAS

Karyopharm Therapeutics, Inc.

US$7.98

Price Arrow0.51 (6.83%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Consensus ValueHALO Earnings MomentumHALO GrowthHALO Momentum+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Karyopharm Therapeutics, Inc. Overview

KPTI Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About KPTI

icon

Telephone

1.617.658.0600

icon

Address

2nd floor, Suite 210, 85 Wells Avenue, Newton, MA 02459-3298

Description

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A. Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008 and is headquartered in Newton, MA.

KPTI Price Chart

Key Stats

Market Cap

US$169.29M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 3.65 - 10.99

Trade Value (12mth)

US$715,942.00

1 week

-2.61%

1 month

-18.54%

YTD

3.89%

1 year

58.94%

All time high

735.08

Key Fundamentals

EPS 3 yr Growth

-40.80%

EBITDA Margin

-61.90%

Operating Cashflow

-$75m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

-2.00

Quick Ratio

1.10

Other Data

Shares Outstanding (Fully Diluted)

25m

HALO Sector

Healthcare

Next Company Report Date

10-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

KPTI Announcements

Latest Announcements

DateAnnouncements
14 May 26
14 May 26
14 May 26
14 May 26
14 May 26

KPTI Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-18.79-9.41-17.93locklocklock
EPS (Fully Diluted)
$locklocklocklock-18.79-9.41-17.93locklocklock
Growth
%locklocklocklock37.949.9-90.6locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Karyopharm Therapeutics, Inc. (KPTI:NAS)?
Halo FAQ
The current share price of Karyopharm Therapeutics, Inc. (KPTI:NAS) is USD$7.98.
What is the 52-week high share price for Karyopharm Therapeutics, Inc. (KPTI:NAS)?
Halo FAQ
The 52-week high share price for Karyopharm Therapeutics, Inc. (KPTI:NAS) is USD$10.99.
What is the 52-week low share price for Karyopharm Therapeutics, Inc. (KPTI:NAS)?
Halo FAQ
The 52-week low share price for Karyopharm Therapeutics, Inc. (KPTI:NAS) is USD$3.65.
What is the dividend yield for Karyopharm Therapeutics, Inc. (KPTI:NAS)?
Halo FAQ
Karyopharm Therapeutics, Inc. (KPTI:NAS) does not pay a dividend.
What was Karyopharm Therapeutics, Inc. (KPTI:NAS) last dividend payment?
Halo FAQ
Karyopharm Therapeutics, Inc. (KPTI:NAS) does not pay a dividend.
What is the franking level for Karyopharm Therapeutics, Inc. (KPTI:NAS)?
Halo FAQ
Karyopharm Therapeutics, Inc. (KPTI:NAS) has a franking level of 0.00%.
In which sector is Karyopharm Therapeutics, Inc. (KPTI:NAS) classified?
Halo FAQ
Karyopharm Therapeutics, Inc. (KPTI:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.